- Genprex Inc Global One Media Interview TranscriptJun 22, 2023
- Genprex Inc at Sidoti & Company May Micro-Cap Virtual Conference TranscriptMay 11, 2023
- Genprex Inc KOL Event: Novel Gene Therapy to Treat Type 1 Diabetes TranscriptApr 12, 2023
- Genprex Inc at LD Micro Main Event TranscriptOct 26, 2022
- Genprex Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Genprex Inc at LD Micro Invitational Conference (Virtual) TranscriptJun 08, 2022
- Genprex Inc at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 20, 2022
- Genprex Inc at Benzinga Healthcare Small Cap Conference (Virtual) TranscriptSep 29, 2021
- Genprex Inc C-Suite Interview with Noble Capital Markets TranscriptApr 22, 2021
- Cell and Gene Meeting on Mesa - Genprex TranscriptJan 08, 2021
- Genprex launches new branding for its lead drug REQORSA in preparation for upcoming studies TranscriptNov 06, 2020
- Genprex (GNPX) Virtual Road Show with CEO Rodney Varner TranscriptSep 15, 2020
- Genprex (GNPX) Channelchek C-Suite Series, CEO Rodney Varner interview with Noble's Dr. Ahu Demir TranscriptAug 04, 2020
Genprex (GNPX) Virtual Road Show with CEO Rodney Varner Transcript
Welcome to the Virtual Road Show series presented by Channelchek and Noble Capital Markets.
Of the 6,000 small and microcap companies hosted on Channelchek, today we're featuring Genprex, Nasdaq ticker symbol GNPX. Research coverage of Genprex is provided by Noble Capital Markets. Noble is a FINRA-licensed, SEC-registered broker dealer. All Noble research is available on Channelchek.
Following the formal presentation, Ahu Demir, Noble's Biotechnology Research Analyst covering Genprex will ask our presenter, a selection of the questions received. The source of the questions will remain anonymous. And now here's Rodney Varner, CEO of Genprex to make the presentation. Rodney, take it away.
Okay, thanks very much. Thanks to Noble for giving me the opportunity to present today. I'm Rodney Varner, Founder, Chairman, and CEO of Genprex.
At Genprex, we're reprogramming the course of cancer and diabetes through gene therapies. I know that this audience has seen the forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)